The Silzone effect: How to reconcile contradictory reports?

European Journal of Cardio-thoracic Surgery

Volumn 25, Issue 3, 2004, Pages 371-375

  Grunkemeier, Gary L ^a,b   Wu, YingXing ^a  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b PROVIDENCE ST VINCENT MEDICAL CENTER   (United States)

Author keywords

Paravalvular leak; Silzone heart valve; St. Jude Medical heart valve; Thromboembolism

Indexed keywords

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; ENDOCARDITIS; HEART VALVE PROSTHESIS; HUMAN; INCIDENCE; PRIORITY JOURNAL; SAINT JUDE HEART VALVE PROSTHESIS; THROMBOEMBOLISM;

ENDOCARDITIS; HEART VALVE PROSTHESIS; HUMANS; MULTICENTER STUDIES; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; THROMBOEMBOLISM;

EID: 1542613961     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2003.12.014     Document Type: Article

References (25)

1. Schaff H.V., Carrel T.P., Jamieson W.R., Jones K.W., Rufilanchas J.J., Cooley D.A., Hetzer R., Stumpe F., Duveau D., Moseley P., van Boven W.J., Grunkemeier G.L., Kennard E.D., Holubkov R. Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT. Ann Thorac Surg. 73:(3):2002;785-792.
2. Ionescu A., Fraser A.G., Butchart E.G. Unexpectedly high incidence of embolic events with the St Jude Silzone valve. Eur Heart J. 20:1999;558.
3. Ionescu A.A., Fraser A.G., Butchart E.G. High incidence of embolism after St Jude Silzone prosthetic valve implantation. Circulation. 100:1999;I-524.
4. Herijgers P., Herregods M.C., Vandeplas A., Meyns B., Flameng W. Silzone coating and paravalvular leak: an independent, randomized study. J Heart Valve Dis. 10:(6):2001;712-715. Discussion pp. 715-716.
5. Stalenhoef J.E., Mellema E.C., Veeger N.J., Ebels T. Thrombogenicity and reoperation of the St. Jude Silzone Valve: a comparison with the conventional St. Jude Valve. J Heart Valve Dis. 12:(5):2003;635-639.
6. Horstkotte D., Bergemann R. Thrombogenicity of the St. Jude medical prosthesis with and without silzone-coated sewing cuffs. Ann Thorac Surg. 71:(3):2001;1065.
7. Brutel de la Riviere A., Dossche K.M., Birnbaum D.E., Hacker R. First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis. 9:(1):2000;123-129. Discussion pp. 129-130.
8. Auer J., Berent R., Ng C.K., Punzengruber C., Mayr H., Lassnig E., Schwarz C., Puschmann R., Hartl P., Eber B. Early investigation of silver-coated Silzone heart valves prosthesis in 126 patients. J Heart Valve Dis. 10:(6):2001;717-723.
9. Houel R., Kirsch M., Hillion M.L., Loisance D. Silzone-coated St. Jude medical valve: a safe valve. J Heart Valve Dis. 10:(6):2001;724-727.
10. Ionescu A., Payne N., Fraser A.G., Giddings J., Grunkemeier G.L., Butchart E.G. Incidence of embolism and paravalvar leak after St Jude Silzone valve implantation: experience from the Cardiff Embolic Risk Factor Study. Heart. 89:(9):2003;1055-1061.
11. Schaff H, Kennard ED, Holubkov R, Dávila-Román VG. In: AVERT Investigators' Meeting, San Diego, CA; January 31, 2003.
12. Schaff H., Carrel T., Steckelberg J.M., Grunkemeier G.L., Holubkov R. Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis. 8:(2):1999;131-139.
13. Carrel T., Nguyen T., Kipfer B., Althaus U. Definitive cure of recurrent prosthetic endocarditis using silver-coated St. Jude Medical heart valves: a preliminary case report. J Heart Valve Dis. 7:(5):1998;531-533.
14. Garcia Fuster R., Montero Argudo J.A., Gil Albarova O., Hornero Sos F., Canovas S., Dalmau Sorli M.J. Employment of St. Jude 'silzone' valve in the surgical treatment of early prosthetic valve endocarditis: a preliminary case report and review of the literature. Rev Esp Cardiol. 53:(1):2000;139-141.
15. Bertrand S., Houel R., Vermes E., Soustelle C., Hillion M.L., Loisance D. Preliminary experience with Silzone-coated St. Jude medical valves in acute infective endocarditis. J Heart Valve Dis. 9:(1):2000;131-134.
16. Kjaergard H.K., Tingleff J., Abildgaard U., Pettersson G. Recurrent endocarditis in silver-coated heart valve prosthesis. J Heart Valve Dis. 8:(2):1999;140-142.
17. Tozzi P., Al-Darweesh A., Vogt P., Stumpe F. Silver-coated prosthetic heart valve: a double-bladed weapon. Eur J Cardiothorac Surg. 19:(5):2001;729-731.
18. Cooper M.H., Onsager D.R., Ende D., Chopra P.S. Prosthetic valve endocarditis occurring on a silzone coated heart valve used as treatment for rheumatic mitral valve disease. Eur J Cardiothorac Surg. 21:(1):2002;158-159.
19. Butany J., Scully H.E., VanArsdell G., Leask R. Prosthetic heart valves with silver-coated sewing cuff fabric: early morphological features in two patients. Can J Cardiol. 18:(7):2002;733-738.
20. Edmunds L.H. Jr, Clark R.E., Cohn L.H., Grunkemeier G.L., Miller D.C., Weisel R.D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg. 10:1996;812-816.
21. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
22. Cox D.R. Some simple approximate test for Poisson variates. Biometrika. 40:1953;354-360.
23. Grunkemeier G.L., Anderson W.N. Jr. Clinical evaluation and analysis of heart valve substitutes. J Heart Valve Dis. 7:1998;163-169.
24. Division of Cardiovascular, Respiratory, and Neurological Devices, Center for Devices and Radiological Health, Food and Drug Administration. Draft Replacement Heart Valve Guidance, Version 4.1; 1994.
25. Bodnar E. The Silzone dilemma - what did we learn? J Heart Valve Dis. 9:(2):2000;170-173.